Keith L. Knutson
Department of Immunology
College of Medicine, Mayo Clinic
Keith L. Knutson has not added Biography.
If you are Keith L. Knutson and would like to personalize this page please email our Author Liaison for assistance.
Expert opinion on biological therapy Jan, 2002 | Pubmed ID: 11772340
Blood Apr, 2002 | Pubmed ID: 11929774
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2002 | Pubmed ID: 12006513
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun, 2002 | Pubmed ID: 12039923
Current opinion in investigational drugs (London, England : 2000) Jan, 2002 | Pubmed ID: 12054067
Human immunology Jul, 2002 | Pubmed ID: 12072190
Current opinion in molecular therapeutics Aug, 2002 | Pubmed ID: 12222879
Journal of clinical immunology Jan, 2003 | Pubmed ID: 12645861
Cancer chemotherapy and biological response modifiers , 2002 | Pubmed ID: 12703214
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
Nature medicine May, 2003 | Pubmed ID: 12704383
Immunobiology , 2003 | Pubmed ID: 12777059
Hematology/oncology clinics of North America Aug, 2003 | Pubmed ID: 12959191
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity.
Molecular cancer therapeutics Oct, 2003 | Pubmed ID: 14578464
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2003 | Pubmed ID: 14654536
Cancer research Feb, 2004 | Pubmed ID: 14871850
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2004 | Pubmed ID: 15143085
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
Nature medicine Sep, 2004 | Pubmed ID: 15322536
Cancer chemotherapy and biological response modifiers , 2003 | Pubmed ID: 15338750
Journal of clinical immunology Sep, 2004 | Pubmed ID: 15359116
Breast disease , 2004 | Pubmed ID: 15687702
Cancer immunology, immunotherapy : CII Jan, 2006 | Pubmed ID: 15891880
Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals".
Breast cancer research and treatment Apr, 2006 | Pubmed ID: 16211331
Frontiers in bioscience : a journal and virtual library , 2006 | Pubmed ID: 16368569
Cancer research Jan, 2006 | Pubmed ID: 16424052
Molecular cancer therapeutics Jan, 2006 | Pubmed ID: 16432173
Journal of immunology (Baltimore, Md. : 1950) Jul, 2006 | Pubmed ID: 16785502
Future oncology (London, England) Jun, 2006 | Pubmed ID: 16787118
Cancer immunology, immunotherapy : CII Mar, 2007 | Pubmed ID: 16819631
Journal of immunology (Baltimore, Md. : 1950) Aug, 2006 | Pubmed ID: 16849459
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep, 2006 | Pubmed ID: 16908932
Cancer research Oct, 2006 | Pubmed ID: 17018635
Cancer research Feb, 2007 | Pubmed ID: 17283170
HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses.
European journal of immunology Mar, 2007 | Pubmed ID: 17304628
Journal of immunology (Baltimore, Md. : 1950) Mar, 2007 | Pubmed ID: 17339455
Clinical cancer research : an official journal of the American Association for Cancer Research Mar, 2007 | Pubmed ID: 17363545
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2007 | Pubmed ID: 17404089
The American journal of pathology Jun, 2007 | Pubmed ID: 17525251
Tumor immunoediting and immunosculpting pathways to cancer progression.
Seminars in cancer biology Aug, 2007 | Pubmed ID: 17662614
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2007 | Pubmed ID: 17785568
Blood Feb, 2008 | Pubmed ID: 18029553
Gynecologic oncology Mar, 2008 | Pubmed ID: 18222534
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors.
Cancer research Apr, 2008 | Pubmed ID: 18381452
Cancer research Jun, 2008 | Pubmed ID: 18559537
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
Cancer research Apr, 2009 | Pubmed ID: 19276366
BMC cancer , 2009 | Pubmed ID: 19500386
Gastroenterology Oct, 2009 | Pubmed ID: 19577568
PloS one , 2009 | Pubmed ID: 19617914
Cancer immunology, immunotherapy : CII Jan, 2010 | Pubmed ID: 19621224
Therapeutic vaccines for malignant brain tumors.
Biologics : targets & therapy Dec, 2008 | Pubmed ID: 19707456
Expert review of neurotherapeutics Jul, 2003 | Pubmed ID: 19810935
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
Breast cancer research and treatment Aug, 2010 | Pubmed ID: 19898981
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2010 | Pubmed ID: 20103660
Cancer immunology, immunotherapy : CII Jun, 2010 | Pubmed ID: 20140431
AIDS (London, England) Jun, 2010 | Pubmed ID: 20299954
Cancer research Apr, 2010 | Pubmed ID: 20395197
Journal of immunology (Baltimore, Md. : 1950) Jun, 2010 | Pubmed ID: 20483795
Journal of immunology (Baltimore, Md. : 1950) Jun, 2010 | Pubmed ID: 20495063
Journal of translational medicine , 2010 | Pubmed ID: 20529245
Cancer biomarkers : section A of Disease markers , 2010 | Pubmed ID: 20938089
Cancer causes & control : CCC May, 2011 | Pubmed ID: 21359843
Arthritis and rheumatism Jun, 2011 | Pubmed ID: 21384332
Immunotherapy Apr, 2011 | Pubmed ID: 21463194
Journal of immunology (Baltimore, Md. : 1950) Jun, 2011 | Pubmed ID: 21551365
Cancer research Jul, 2011 | Pubmed ID: 21555371
Journal of immunology (Baltimore, Md. : 1950) Jul, 2011 | Pubmed ID: 21613617
Clinical immunology (Orlando, Fla.) Oct, 2011 | Pubmed ID: 21703930
The American journal of pathology Jan, 2012 | Pubmed ID: 22067909
Mayo Clinic proceedings. Mayo Clinic Jan, 2012 | Pubmed ID: 22212964
Arthritis research & therapy , 2012 | Pubmed ID: 22293286
À PROPOS DE JoVE
Copyright © 2025 MyJoVE Corporation. Tous droits réservés.